Streetbeat News

Price Targets

MRVI

Goldman Sachs analyst Matthew Sykes maintains a Neutral rating on Maravai LifeSciences (NASDAQ:MRVI) and lowers the price target from $8 to $7.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:19 pm

LB

Goldman Sachs analyst John Mackay has maintained a Buy rating on LandBridge (NYSE:LB) and raised the price target from $38 to $43.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:18 pm

CVX

RBC Capital analyst Biraj Borkhataria has reiterated an Outperform rating on Chevron (NYSE:CVX) and maintained a price target of $170.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:17 pm

JELD

Goldman Sachs analyst Susan Maklari maintains a Neutral rating on JELD-WEN Holding (NYSE:JELD) but raises the price target from $15 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:16 pm

EVH

RBC Capital analyst Sean Dodge has reiterated an Outperform rating on Evolent Health (NYSE:EVH) and maintained a price target of $42.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:14 pm

FBIN

Goldman Sachs analyst Susan Maklari has maintained a Buy rating on Fortune Brands (NYSE:FBIN) and raised the price target from $86 to $98.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:12 pm

FTRE

Goldman Sachs analyst Matthew Sykes has maintained a Neutral rating on Fortrea Holdings (NASDAQ:FTRE) while lowering the price target from $26 to $23.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:11 pm

BAP

Goldman Sachs analyst Tito Labarta maintains a Sell rating on Credicorp (NYSE:BAP) but raises the price target from $143 to $160.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:10 pm

XOM

RBC Capital analyst Biraj Borkhataria has reiterated a Sector Perform rating for Exxon Mobil (NYSE:XOM) and maintained a price target of $120.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:09 pm

HUM

RBC Capital analyst Ben Hendrix maintains an Outperform rating on Humana (NYSE:HUM) but lowers the price target from $400 to $265.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:06 pm